Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;16(4):e13548.
doi: 10.1111/1753-0407.13548.

Association of advanced glycation end products with ear lobe crease: A cross-sectional study

Affiliations

Association of advanced glycation end products with ear lobe crease: A cross-sectional study

Yuepeng Wang et al. J Diabetes. 2024 Apr.

Abstract

Objective: Several studies have demonstrated a significant association between the presence of the ear lobe crease (ELC) and cardiovascular disease. Advanced glycation end-products (AGEs) can affect the structures and functions of proteins and contribute to the development of diabetic complications. However, few studies have reported the relationship between AGEs and ELC. The purpose of this study was to investigate the correlation of skin autofluorescence (SAF)-AGEage (SAF-AGEs × age/100) with ELC.

Methods: This cross-sectional study enrolled 6500 eligible participants from two communities in Beijing. Skin autofluorescence (SAF) was used to measure skin AGEs (SAF-AGEs). SAF-AGEage was defined as AGEs × age/100. Binary logistic regression analysis and linear regression analysis nested in logistic models were applied to test outcomes.

Results: The overall prevalence of ELC with an average age of 62.7 years participants was 57.1% (n = 3714). Age, fasting blood glucose, systolic blood pressure, and lipoprotein cholesterol were all greater in participants with ELC. ELC-positive participants had higher prevalence of coronary heart disease. Logistic analysis showed a significantly positive relationship between quartiles of SAF-AGEage and ELC (odds ratio [OR] 1.526, 95% CI 1.324-1.759; OR 2.072, CI 1.791-2.396; and OR 2.983, CI 2.551-3.489) for the multivariate-adjusted models, respectively. Stratified research revealed that those with a history of diabetes, hypertension, or coronary heart disease experienced the connection between SAF-AGEage and ELC.

Conclusion: ELC is associated with coronary heart disease, and the SAF-AGE has a potential role in ELC development in elder people.

Keywords: advanced glycation end products; cardiovascular disease; ear lobe crease; type 2 diabetes.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Schematic of patient's ear lobe crease. A 61‐year‐old woman with a background of diabetes mellitus, hypertension, and hyperlipidemia was observed with earlobe crease. Angiography revealed severe triple vessel disease.
FIGURE 2
FIGURE 2
The prevalence of CHD (A) and ELC (B) in different tertiles of SAF‐AGEage levels in middle‐aged or elderly Chinese participants. AGE, advanced glycation end product; CHD, coronary heart disease; ELC, earlobe crease; Q, quartile; SAF, skin autofluorescence.

References

    1. Kaukola S, Manninen V, Valle M, Halonen PI. Ear‐lobe crease and coronary atherosclerosis. Lancet. 1979;2:1377. - PubMed
    1. Shmilovich H, Cheng VY, Rajani R, et al. Relation of diagonal ear lobe crease to the presence, extent, and severity of coronary artery disease determined by coronary computed tomography angiography. Am J Cardiol. 2012;109(9):1283‐1287. - PubMed
    1. Glavic J, Cerimagic D, Lovrencic‐Huzjan A, Vukovic V, Demarin V. Frank's sign as a risk factor for cerebrovascular disease. Atherosclerosis. 2008;196:477‐478. - PubMed
    1. Xu J, Wang L, Zhang C, et al. The prognostic value of deep earlobe creases in patients with acute ischemic stroke. Front Cardiovasc Med. 2023;10:1096044. - PMC - PubMed
    1. Lucenteforte E, Romoli M, Zagli G, Gensini GF, Mugelli A, Vannacci A. Ear lobe crease as a marker of coronary artery disease: a meta‐analysis. Inte J Cardiol. 2014;175:171‐175. - PubMed

Substances

LinkOut - more resources